Riskpilot← Back to searchSign inGet full accessGAUS CONSULT AS
ASActiveOrg 984920571Johan Stangs Plass 2, 1767 HaldenPhysiotherapy activities · NACE 8695Est. 20025 employees
Revenue 2024
NOK 12,7M
-35% vs 2023
EBITDA margin
37.0%
-58% vs 2023
Equity ratio
13.8%
Financial strength
Net profit 2024
NOK 778K
-88% vs 2023
| Revenue | NOK 12,7M | -35% |
| EBITDA | NOK 4,7M | -58% |
| Net profit | NOK 778K | -88% |
| Total assets | NOK 98,6M | +12% |
| Equity | NOK 13,6M | -1% |
| Employees | 5 | — |
Legal name
GAUS CONSULT AS
Org number
984920571
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
2. oktober 2002
Share capital
NOK 85 700
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Import-/eksportvirksomhet, konsulent- og rådgivningsvirksomhet, fysioterapi, osteopati, akupunktur, manuell terapi og alt som hører med under alternative behandlingsformer. Kjøp og salg av behandlingsprodukter, helsekost, hygieneartikler m.v. Kjøp, salg, leie, eie og drift av fast eiendom, samt all virksomhet som står i forbindelse herved. Utleie av arbeidskraft og salg av håndverkertjenester. Kjøp og salg av aksjer eller på annen måte gjøre seg interessert i andre foretagender.
Address
Johan Stangs Plass 2, 1767 Halden
Phone
+4740622061
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3 105 | 3 517 | 3 850 | 4 654 | 7 597 | 6 921 | 7 173 | 6 289 | 6 742 | 7 601 | 7 143 | 13 889 | 7 936 | 8 088 | 11 295 | 19 668 | 12 707 |
| Staff expenses | −1 512 | −1 172 | −1 073 | −1 189 | −1 456 | −2 343 | −2 523 | −2 538 | −2 670 | −2 622 | −2 686 | −2 724 | −2 657 | −2 679 | −2 620 | −2 601 | −3 528 |
| EBITDA | 236 | 867 | 1 130 | 1 602 | 3 996 | 1 749 | 2 769 | 1 571 | 1 862 | 2 675 | 1 666 | 7 345 | 2 862 | 1 899 | 4 651 | 11 175 | 4 703 |
| Depreciation & amort. | −56 | −65 | −79 | −109 | −147 | −132 | −183 | −301 | −423 | −446 | −452 | −316 | −170 | −234 | −241 | −239 | −225 |
| EBIT | 181 | 802 | 1 052 | 1 493 | 3 849 | 1 617 | 2 586 | 1 270 | 1 439 | 2 229 | 1 213 | 7 029 | 2 693 | 1 666 | 4 411 | 10 936 | 4 478 |
| Net financials | −788 | −627 | −497 | −977 | −2 702 | −1 098 | 518 | −1 744 | −3 800 | −594 | −1 726 | −3 142 | −4 455 | −1 843 | −2 086 | −3 926 | −3 472 |
| Profit before tax | −607 | 175 | 554 | 516 | 1 147 | 520 | 3 104 | −475 | −2 360 | 1 636 | −513 | 3 887 | −1 763 | −177 | 2 324 | 7 010 | 1 006 |
| Tax | −142 | 44 | 90 | 149 | 664 | 89 | 369 | −91 | 20 | 211 | −152 | 1 032 | 207 | 30 | 542 | 694 | 228 |
| Net profit | −466 | 130 | 464 | 367 | 483 | 431 | 2 735 | −384 | −2 381 | 1 424 | −361 | 2 855 | −1 970 | −207 | 1 782 | 6 316 | 778 |
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 11 873 | 20 779 | 20 983 | 29 812 | 37 159 | 30 208 | 36 222 | 41 470 | 43 197 | 51 642 | 60 974 | 58 792 | 55 376 | 61 646 | 74 573 | 88 340 | 98 638 |
| Equity | 778 | 908 | 1 373 | 1 868 | 2 351 | 2 782 | 5 517 | 5 133 | 2 553 | 3 477 | 3 046 | 5 901 | 2 581 | 5 590 | 7 372 | 13 688 | 13 610 |
| Long-term debt | 10 435 | 19 559 | 18 692 | 27 355 | 34 437 | 25 837 | 27 406 | 35 393 | 39 619 | 41 602 | 50 960 | 43 213 | 47 389 | 54 362 | 59 986 | 69 566 | 75 479 |
| Short-term debt | 660 | 312 | 918 | 590 | 371 | 1 589 | 3 298 | 943 | 1 026 | 6 562 | 6 968 | 9 678 | 5 406 | 1 693 | 7 215 | 5 087 | 9 548 |
| Total debt | 11 095 | 19 871 | 19 610 | 27 944 | 34 808 | 27 426 | 30 704 | 36 336 | 40 645 | 48 165 | 57 928 | 52 891 | 52 795 | 56 055 | 67 201 | 74 652 | 85 027 |
EBITDA margin
37.0%
This company
15.8%
Market median
+134% vs market
20082024
Equity ratio
13.8%
This company
38.2%
Market median
-64% vs market
20082024
Return on equity
5.7%
This company
18.4%
Market median
-69% vs market
20082024
Net profit margin
6.1%
This company
8.1%
Market median
-25% vs market
20082024
Asset turnover
0.13×
This company
1.12×
Market median
-88% vs market
20082024
Debt / equity
6.25×
This company
0.62×
Market median
-908% vs market
20082024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JE Deputy Member | Deputy Member | 2002 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2002 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of GAUS CONSULT AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Erik Dahl | Deputy Member | 0 companies |
| Bjørn Runar Dahl | Chairman | 0 companies |